USA • New York Stock Exchange • NYSE:RBOT • US92561V2088
The current stock price of RBOT is 1.86 USD. In the past month the price decreased by -32.85%. In the past year, price decreased by -87.6%.
ChartMill assigns a fundamental rating of 2 / 10 to RBOT. No worries on liquidiy or solvency for RBOT as it has an excellent financial health rating, but there are worries on the profitability.
Over the last trailing twelve months RBOT reported a non-GAAP Earnings per Share(EPS) of -9.05. The EPS increased by 12.05% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -182.62% | ||
| ROE | -380.42% | ||
| Debt/Equity | 0 |
6 analysts have analysed RBOT and the average price target is 5.1 USD. This implies a price increase of 174.19% is expected in the next year compared to the current price of 1.86.
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 19.78 | 197.518B | ||
| ISRG | INTUITIVE SURGICAL INC | 48.54 | 175.875B | ||
| SYK | STRYKER CORP | 24.05 | 139.086B | ||
| BSX | BOSTON SCIENTIFIC CORP | 20.98 | 108.957B | ||
| IDXX | IDEXX LABORATORIES INC | 43.78 | 51.801B | ||
| BDX | BECTON DICKINSON AND CO | 11.46 | 51.46B | ||
| EW | EDWARDS LIFESCIENCES CORP | 26.68 | 46.035B | ||
| RMD | RESMED INC | 21.14 | 37.897B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 15.77 | 36.095B | ||
| DXCM | DEXCOM INC | 26.99 | 26.58B |
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
Vicarious Surgical, Inc. a blank check company, which engages in effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company is headquartered in Waltham, Massachusetts and currently employs 123 full-time employees. The company went IPO on 2020-09-04. The firm is combining advanced miniaturized robotics, computer science, sensing and three-dimensional (3D) visualization to build a single-port surgical robot, called the Vicarious Surgical System, that helps surgeons to perform minimally invasive surgery. The Vicarious Surgical System is capable of incision sizes of approximately 1.8 centimeters. The Vicarious Surgical System consists of a camera and instrument arms, surgeon console and patient cart. The Vicarious Surgical System has a high-performance stereoscopic camera that, when combined with robotic motion, provides full 360-degree viewing capability and is being developed to continuously map the depth of the abdominal cavity. The Vicarious Surgical System surgeon console is designed to provide all the systems necessary for the surgeon in visualizing the surgical field and controlling all the motions of the robot.
VICARIOUS SURGICAL INC-A
78 Fourth Avenue
Waltham MASSACHUSETTS US
CEO: David Chu
Employees: 123
Phone: 16178681700
Vicarious Surgical, Inc. a blank check company, which engages in effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company is headquartered in Waltham, Massachusetts and currently employs 123 full-time employees. The company went IPO on 2020-09-04. The firm is combining advanced miniaturized robotics, computer science, sensing and three-dimensional (3D) visualization to build a single-port surgical robot, called the Vicarious Surgical System, that helps surgeons to perform minimally invasive surgery. The Vicarious Surgical System is capable of incision sizes of approximately 1.8 centimeters. The Vicarious Surgical System consists of a camera and instrument arms, surgeon console and patient cart. The Vicarious Surgical System has a high-performance stereoscopic camera that, when combined with robotic motion, provides full 360-degree viewing capability and is being developed to continuously map the depth of the abdominal cavity. The Vicarious Surgical System surgeon console is designed to provide all the systems necessary for the surgeon in visualizing the surgical field and controlling all the motions of the robot.
The current stock price of RBOT is 1.86 USD. The price decreased by -6.53% in the last trading session.
RBOT does not pay a dividend.
RBOT has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
RBOT stock is listed on the New York Stock Exchange exchange.
VICARIOUS SURGICAL INC-A (RBOT) currently has 123 employees.
VICARIOUS SURGICAL INC-A (RBOT) has a market capitalization of 12.18M USD. This makes RBOT a Nano Cap stock.